1. Home
  2. ORIS vs SPRC Comparison

ORIS vs SPRC Comparison

Compare ORIS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$0.47

Market Cap

3.1M

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$4.50

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIS
SPRC
Founded
2014
2004
Country
China
Israel
Employees
69
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ORIS
SPRC
Price
$0.47
$4.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
472.4K
302.6K
Earning Date
04-30-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$152.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.27
52 Week High
$1.87
$9.03

Technical Indicators

Market Signals
Indicator
ORIS
SPRC
Relative Strength Index (RSI) 46.39 39.14
Support Level $0.43 $3.46
Resistance Level $0.62 $4.85
Average True Range (ATR) 0.05 0.69
MACD 0.02 -0.43
Stochastic Oscillator 41.18 0.00

Price Performance

Historical Comparison
ORIS
SPRC

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: